Related references
Note: Only part of the references are listed.A High-Content, Live-Cell, and Real-Time Approach to the Quantitation of Ligand-Induced β-Arrestin2 and Class A/Class B GPCR Mobilization
Anthony P. Leonard et al.
MICROSCOPY AND MICROANALYSIS (2013)
Biasing the Parathyroid Hormone Receptor: Relating In Vitro Ligand Efficacy to In Vivo Biological Activity
Kathryn M. Appleton et al.
G PROTEIN COUPLED RECEPTORS: MODELING, ACTIVATION, INTERACTIONS AND VIRTUAL SCREENING (2013)
TRV120027, a Novel β-Arrestin Biased Ligand at the Angiotensin II Type I Receptor, Unloads the Heart and Maintains Renal Function When Added to Furosemide in Experimental Heart Failure
Guido Boerrigter et al.
CIRCULATION-HEART FAILURE (2012)
Gene expression profiling in glomeruli of diabetic nephropathy rat
Qian Zhang et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2012)
Deciphering biased-agonism complexity reveals a new active AT1 receptor entity
Aude Sauliere et al.
NATURE CHEMICAL BIOLOGY (2012)
Global Renal Gene Expression Profiling Analysis in B2-Kinin Receptor Null Mice: Impact of Diabetes
Miran A. Jaffa et al.
PLOS ONE (2012)
RAS-Mediated Adaptive Mechanisms in Cardiovascular Tissues: Confounding Factors of RAS Blockade Therapy and Alternative Approaches
Rukhsana Gul et al.
CARDIORENAL MEDICINE (2012)
A cleavable signal peptide enhances cell surface delivery and heterodimerization of Cerulean-tagged angiotensin II AT1 and bradykinin B2 receptor
Ursula Quitterer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Cardiorenal Actions of TRV120027, a Novel β-Arrestin-Biased Ligand at the Angiotensin II Type I Receptor, in Healthy and Heart Failure Canines A Novel Therapeutic Strategy for Acute Heart Failure
Guido Boerrigter et al.
CIRCULATION-HEART FAILURE (2011)
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials
Ausilia Maione et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
The angiotensin II type 1 receptor antagonist Losartan binds and activates bradykinin B2 receptor signaling
Marie Mi Bonde et al.
REGULATORY PEPTIDES (2011)
Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery
Terry Kenakin et al.
PHARMACOLOGICAL REVIEWS (2010)
c-Src-mediated phosphorylation of AP-2 reveals a general mechanism for receptors internalizing through the clathrin pathway
Brandon Zimmerman et al.
CELLULAR SIGNALLING (2009)
Lack of Evidence for AT1R/B2R Heterodimerization in COS-7, HEK293, and NIH3T3 Cells HOW COMMON IS THE AT1R/B2R HETERODIMER?
Jakob L. Hansen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Functional interactions between 7TM receptors in the Renin-Angiotensin System-Dimerization or crosstalk?
Christina Lyngso et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli
Zhong-Gao Xu et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system
Alvin H. Schmaier
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Role of β-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription
Mi-Hye Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy
Yan Tan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit
Oliver P. Ernst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein
Matthew R. Whorton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Puja K. Mehta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
The angiotensin II AT(1), receptor structure-activity correlations in the light of rhodopsin structure
Laerte Oliveira et al.
PHYSIOLOGICAL REVIEWS (2007)
Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II
L Hunyady et al.
MOLECULAR ENDOCRINOLOGY (2006)
Dissociation of β-arrestin from internalized bradykinin B2 receptor is necessary for receptor recycling and resensitization
M Simaan et al.
CELLULAR SIGNALLING (2005)
High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based β-arrestin2 recruitment assay
FF Hamdan et al.
JOURNAL OF BIOMOLECULAR SCREENING (2005)
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers - A meta-analysis
JS Healey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Mesangial AT(1)/B-2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension
S AbdAlla et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2005)
Mechanisms of angiotensin II-induced expression of B2 kinin receptors
Y Tan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl
EF Nemeth et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Dual inhibition of β-adrenergic and angiotensin II receptors by a single antagonist -: A functional role for receptor-receptor interaction in vivo
L Barki-Harrington et al.
CIRCULATION (2003)
Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2
HJ Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction
AH Schmaier
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
Plasma prekallikrein - A risk marker for hypertension and nephropathy in type 1 diabetes
AA Jaffa et al.
DIABETES (2003)
Regulation of cardiac bradykinin B1- and B2-receptor mRNA in experimental ischemic, diabetic, and pressure-overload-induced cardiomyopathy
F Spillmann et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2002)
Drugs targeting the renin-angiotensin-aldosterone system
MA Zaman et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications
T Nagai et al.
NATURE BIOTECHNOLOGY (2002)
Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking
LA Devi
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness
S AbdAlla et al.
NATURE MEDICINE (2001)
Vasoactive potential of the B1 bradykinin receptor in normotension and hypertension
I Duka et al.
CIRCULATION RESEARCH (2001)
AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration
S AbdAlla et al.
NATURE (2000)
Oligomerization of μ- and δ-opioid receptors -: Generation of novel functional properties
SR George et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A trafficking checkpoint controls GABAB receptor heterodimerization
M Margeta-Mitrovic et al.
NEURON (2000)
Agonist-induced phosphorylation of the angiotensin II (AT1A) receptor requires generation of a conformation that is distinct from the inositol phosphate-signaling state
WG Thomas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)